Inattention News and Research

RSS

Anti-inflammatory function of Alzheimer's disease drugs revealed

The mechanism in anti-Alzheimer's disease drugs that inhibits the production of a destructive, inflammation-causing protein in the brain has been revealed by researchers at the Hebrew university of Jerusalem.

28 Jul 2005

Young children who snore more likely to be hyperactive later on

A new study has found that young children who snore could possibly be at greater risk of becoming hyperactive later, than those who sleep quietly.

4 Jul 2005

Children who snore are far more likely to suffer hyperactivity disorders

Several years ago, University of Michigan researchers published some of the strongest evidence yet that children who snore when they sleep are far more likely to have attention and hyperactivity problems than their non-snoring peers.

4 Jul 2005

Nearly half of non-ventilated patients in intensive care units experience delirium

A study published today in the open access journal Critical Care reveals for the first time that nearly half of non-ventilated patients in intensive care units (ICU) experience delirium, which is also an independent predictor of longer hospital stay. It was previously though that this was only an issue for mechanically-ventilated ICU patients.

31 May 2005

ADHD costs U.S. nearly $77 billion each year

U.S. household income losses due to attention-deficit/hyperactivity disorder (ADHD) total nearly $77 billion each year, according to a new analysis of the national large-scale survey, "Capturing America's Attention," presented today at the American Psychiatric Association (APA) annual meeting in Atlanta.

23 May 2005

Early home environment and television watching influence bullying behavior

Four-year-old children who receive emotional support and cognitive stimulation from their parents are significantly less likely to become bullies in grade school, but the more television four-year-olds watch the more likely they are to bully later, according to an article in the April issue of the Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

4 Apr 2005

Solving sleep problems helps epileptic children

Sleeping woes may explain why children with epilepsy are often so hyperactive, say researchers with the University of Florida's Evelyn F. and William L. McKnight Brain Institute.

30 Mar 2005

Computerized order entry systems can increase the risk of medication errors

A new study suggests that computerized order entry systems which are implemented in part to reduce prescribing errors can actually increase the risk of medication errors in certain situations, according to a study in the current issue of JAMA.

9 Mar 2005

Early ritalin may cause long-term effects on the brain

A new study conducted in rats by the National Institutes of Health (NIH) and McLean Hospital/Harvard Medical School suggests that the misdiagnosis of attention-deficit hyperactivity disorder (ADHD) combined with prescription drug use in children may lead to a higher risk of developing depressive symptoms in adulthood.

13 Dec 2004

Boys generally at greater risk of developing attention-deficit/hyperactivity disorder

Boys, in general, and children born to parents who have low education levels, in particular, are at an increased risk for developing attention-deficit/hyperactivity disorder (ADHD) compared to girls and children born to parents with high levels of education, according to a study of 5,701 children in Olmsted County, Minn.

14 Sep 2004

Attention deficit hyperactivity disorder costs the U.S. $77 billion each year

A new analysis of a large-scale survey released today estimates yearly household income losses due to attention deficit hyperactivity disorder (ADHD) within the U.S. at $77 billion, according to Harvard researcher, Joseph Biederman, M.D., co-author of the study.

9 Sep 2004

FDA approval for chewable ADHD tablets

Alliant Pharmaceuticals has announced FDA approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the first, and only, chewable tablet and oral solution for ADHD to gain FDA acceptance.

7 Sep 2004

Stroke severity is the predominant predictor of discharge destination

An article in the July issue of the Archives of Neurology reports that increasing stroke severity, as measured by the National Institutes of Health Stroke Scale, increases the likelihood that stroke patients who are treated with the rt-PA clot-dissolving drug will be discharged to rehabilitation or nursing homes, rather than to their own homes.

20 Jul 2004

Drug helps children with attention deficit/hyperactivity disorder (ADHD)

Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.

3 Jun 2004